Company intelligence / Profile preview

Tekla Healthcare

Boston, Massachusetts, United States

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Tekla Capital Management is a specialist investment adviser focused on the healthcare and life sciences sectors. The firm manages several prominent NYSE-listed closed-end funds, including Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ), and Tekla World Healthcare Fund (THW). Their investment strategy typically involves a combination of public and private equity investments across various sub-sectors such as biotechnology, pharmaceuticals, medical devices, and healthcare services. In 2023, the healthcare fund management business of Tekla was acquired by abrdn, though the funds continue to operate under the Tekla brand identity.

Industry: Investors

Beyond the preview

Go deeper on Tekla Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tekla Healthcare.

Explore the full profile